Work

Study: Too many barriers to MOUD for those incarcerated in jails

Year: 2025

Type: article

Abstract: Researchers have found that out of the 1,243 jails nationwide with medications for opioid use disorder, 65.3% provided buprenorphine, 52.0% provided naltrexone, 45.0% provided methadone, and 27.6% provided all three medications – the only approved medications to treat opioid use disorder. Availability of MOUD was associated with urbanicity, location in a Medicaid expansion state, county opioid overdose rate, and county social vulnerability.

Source: Alcoholism & Drug Abuse Weekly

DOI: 10.1002/adaw.34488

Author: Alison Knopf

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Peace, justice, and strong institutions, Reduced inequalities

Open Access status: bronze

OpenAlex ID: W4409591007

FWCI:

Cites:

Cited by:

Related to: 10